Journals / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 0

Surgical Treatment forProliferative DiabeticRetinopathy

Proliferatif Diabetik Retinopatide Cerrahi Tedavi

Pages
67–73
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review identifies the indications, surgical techniques, anti-VEGF therapies related to surgery, surgical outcomes and complications of pars plana vitrectomy for proliferative diabetic reinopathy and macular edema

📌 3 Key Takeaways

🎯
Objective & Hypothesis:of surgical techniques and technology, indications for surgery in diabetic retinopathy is increasing.
📊
Key Findings & Data:Aside from vitreous hemor- rhage and tractional retinal detachment, patients with macu- lar edema and proliferative complications get early interven- tion.
💡
Conclusion & Impact:This review identifies the indications, surgical techniques, anti-VEGF therapies related to surgery, surgical outcomes and complications of pars plana vitrectomy for proliferative diabetic reinopathy and macular edema
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

of surgical techniques and technology, indications for surgery in diabetic retinopathy is increasing. Aside from vitreous hemor- rhage and tractional retinal detachment, patients with macu- lar edema and proliferative complications get early interven- tion. This review identifies the indications, surgical techniques, anti-VEGF therapies related to surgery, surgical outcomes and complications of pars plana vitrectomy for proliferative diabetic reinopathy and macular edema

Özet

Uygun lazer fotokoagülasyon tedavisi ve medikal tedavi almış olgularda bile proliferatif diabetik retinopatinin geç komplikasyonları için cerrahi tedavi temel teşkil etmektedir. Cerrahi teknikteki ve teknolojideki gelişmelere paralel olarak diabetik retinopatide cerrahi endikasyonlar artmaktadır. Vitreus içi kanamanın ve traksiyonel retina dekolmanının yanı sıra maküla ödemi ve proliferatif komplikasyonlar için cerrahi tedavi günümüzde daha erken uygulanmaktadır. Bu makale güncel endikasyonları, cerrahi teknikleri, cerrahi öncesi ve sırasında kullanılan anti-VEGF tedavileri, cerrahi sonuçları ve komplikasyonları tanımlamaktadır

🔖

Cite This Article

HASANREİSOĞLU, B., ÖZMEN, M. C. (2015). Surgical Treatment forProliferative DiabeticRetinopathy. Retina-Vitreus, Cilt: 23 - Sayı: 0, 67–73. https://ajindex.com/articles/308047

References (12)

  1. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic study of Diabetic Retinopathy, XII: The 14 year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Oph- thalmology 1998;105:1801-15.
  2. Arnos AF, McCarthy DJ, Zimmett P. The rising global burden of diabetes and its complications: Estimates and projectionsto the year 2010. Diabet Med 1997;14:81-5.
  3. Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: Diabetic macular edema. Ophthalmology 1984;91:1464-74.
  4. Gotzaridis EV, Lit ES, D'Amico DJ. Progress in vitreoretinal surgery for proliferative diabetic retinopathy. Semin Ophthalmol 2001;16:31-40.
  5. Gupta V, Gupta A, Dogra MR, et al. Diabetic Retinopathy Atlas and text. New Delhi: Jaypee Brothers Medical Publishers Ltd; 2007. P:75-88.
  6. Hasanreisoğlu B, Özdek Ş. Proliferatif diabetik retinopatinin cerrahi te- davisindeki son gelişmeler. Ret-Vit 2004;12:249-54.
  7. Flynn HW Jr, Chew EY, Simons BD, et al. Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. Ophthalmology 1992; 99: 1351-357. DCCT Research Group. The effect of intensive treatment of diabetes in the development and progression of long term complication in insulin de- pendent diabetes. N Engl J Med 1993;329:977-86.
  8. Rizzo S, Genovesi Ebert F, Di Bartolo E, et al. Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy sur- gery in the treatment of severe proliferative retinopathy (PDR). Grafes Arch Clin Exp Ophthalmol 2008;246:837-42.
  9. Yang CM, Yeh PT, Yang CH, et al. Bevacizumab pretreatment and long acting gas infusion on vitreous clear up after diabetic vitrectomy. Am J Ophthalmol 2008;146:211-7. da R Lucena D, Ribeiro JA, Costa RA, et al. Intraoperative bleeding dur- ing vitrectomy for diabetic tractional detachment with versus without preoperative intravitreal bevacizumab. Br J Ophthalmol 2009;93:688-91.
  10. Oshima Y, Shima C, Wakabayashi T, et al. Microincision vitrectomy sur- gery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment. Ophthalmology 2009;116:927-38.
  11. Modarres M, Nazari H, Falavarjani KG, et al. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol 2009;19:848-52.
  12. Jirawison C, Ittipunkul N. Intravitreal bevacizumab at the end of dia- betic vitrectomy for prevention of postoperative vitreous hemorrhage: A comparative study. J Med Assoc Thai 2